This chemicals company signs a MoU with 3xper Innoventure Ltd, a technological collaboration for new age pharma molecules!
This chemicals company signs a MoU with 3xper Innoventure Ltd, a technological collaboration for new age pharma molecules!

This chemicals company signs a MoU with 3xper Innoventure Ltd, a technological collaboration for new age pharma molecules!

The company has delivered returns of 63 per cent over the past year and returns of 102 per cent from the date of its listing in March 2021.

Siddharth Mane Article rating: 3.9

A leading Indian company specializing in custom synthesis (CSM) and the manufacturing of specialty chemicals.

DSIJ MINDSHARE

Mkt Commentary18-Jul, 2024

Bonus and Spilt Shares18-Jul, 2024

Swing Trading18-Jul, 2024

Mindshare18-Jul, 2024

Mindshare18-Jul, 2024

Knowledge

General9-Jul, 2024

General9-Jul, 2024

General9-Jul, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR